A New Department at the BIOCAD Laboratory
Development of advanced therapy medicinal drugs (ATMD) is the goal of the first Russian Scientific Complex for Development of Genetic Therapy Drugs, a department of promising studies at BIOCAD Lab.
At the gala opening ceremony the Minister of Healthcare Veronika Skvortsova said that R&D Department of BIOCAD is one of the largest in this country, a leader in scientific development of innovative drugs. It is targeted to develop a new area in modern medicine – genetic and cell-based therapeutic drugs capable of treating disorders, that had not responded to treatment, such as herediatary genetic problems, cancer at advanced stages and many others. There are only 13 drugs of that class globally today.
Advanced research department includes three novel laboratories of the international class – molecular genetics, genetic therapy and cytology. They are located at an area of 400 square meters at Neudorf site at special economic zone Saint Petersburg. Alexander Karabelskiy, former Head of Molecular Genetics Laboratory at BIOCAD will be in charge of the new department.